*Aspergillus niger*, a black aspergillus with "generally regarded as safe" status, is widely used in the biotechnological production of organic acids and industrial enzymes[@b1]. As a workhorse of organic acids, *A. niger* is a proficient producer of citrate, which is used extensively in the food and pharmaceutical industries owing to its safety, pleasant acidic taste, high water solubility, and chelating properties[@b2].

If *A. niger* is to be used as a cell factory platform, its genetic background must be thoroughly understood. The available genome sequence of *A. niger* offers a new horizon for both scientific studies and biotechnological applications[@b3]. *A. niger* strains NRRL 3 and ATCC 1015, which can synthesize citrate, have undergone genome-wide analysis[@b1][@b3], and a complete genome-scale metabolic model with genomic annotation has been constructed based on the genome sequence of *A. niger* ATCC 1015[@b4]. Nevertheless, the molecular mechanism of citrate accumulation remains only partially understood[@b5][@b6]. For example, 5 citrate synthases have been identified in ATCC 9029[@b7]; however, the primary gene and the timing of the activity of each enzyme during fermentation remain a mystery. Furthermore, the citrate transporter remains unknown even though the transport process is critical in the production of citrate. In addition, the role of alternative oxidases for energy balance during citrate production must be clarified[@b8].

In this study, the genomes of three *A. niger* strains with different citrate production efficiencies were sequenced, among which the genome of industrial strain *A. niger* H915-1 was sequenced with third-generation sequencing, which provides much longer reads and unbiased genome coverage compared with those of second-generation sequencing. Moreover, transcriptome analysis during citrate fermentation by *A. niger* H915-1 was conducted to explore how the regulation of enzyme expression facilitates citrate accumulation. Finally, the oxaloacetate acetylhydrolase gene (*oah*) was deleted in *A. niger* H915-1 to exam the role of oxalate on pH decrease and citrate production. The results of this study deepen the understanding of citrate accumulation by *A. niger* and provide potential engineering targets for further improvement in citrate production.

Materials and Methods
=====================

Strains
-------

*A. niger* strains H915-1, L2, and A1 were provided by Jiangsu Guoxin Union Energy Co., Ltd (Yixing, Jiangsu Province, China), the third citrate producer in China. Strain H915-1 is an industrial producer, which was generated through several round of compound mutation, whereas strains L2 and A1 are the degenerated isolates of *A. niger* H915-1 during subsequent culture, as filamentous fungi frequently and spontaneously degenerate during maintenance in artificial media due to chromosome instability[@b9]. *Escherichia coli* JM109 was used as a host for recombinant DNA manipulation.

Citrate fermentation by *A. niger* in 50-mL flasks
--------------------------------------------------

For citrate fermentation, conidia were inoculated in seed culture broth (a mixture of corn steep liquor and corn starch with a total sugar content of 10% and total nitrogen content of 0.2%). Eighty milliliters of seed culture was placed in 500-mL flasks and mixed at 250 rpm and 35 °C for 24 h. With 10% inoculum, the fermentation was performed in culture medium (a mixture of corn steep liquor and corn starch with a total sugar content of 16% and total nitrogen content of 0.08%) at 250 rpm and 35 °C until the reducing sugar was exhausted.

Fed-batch cultivations of citrate by *A. niger* H915-1 in a 3-L fermenter
-------------------------------------------------------------------------

Batch cultivations were performed in 3-L fermenters with a working volume of 1.5 L, and the temperature was maintained at 35 °C. For inoculation of the bioreactor, the stirring rate was adjusted to 900 rpm and aeration was set at 3.5 volumes of air per volume of fluid per minute (vvm).

High-performance liquid chromatography analysis
-----------------------------------------------

For quantification of extracellular metabolites, a culture sample was centrifuged at 14,000 × *g* for 5 min. The supernatant was immediately filtered through a filter with a 0.45-μm pore size. The filtrate was kept at −20 °C until for analysis. Citrate and oxalate concentration was detected and quantified with ultraviolet light at 210 nm by using an Amethyst C18-H column (250 × 4.6 mm; Sepax Technologies, Newark, DE, USA). Elution was carried out at 30 °C with 0.01% H~3~PO~4~ at a flow rate of 0.8 mL/min.

Reducing sugar assay
--------------------

Reducing sugar was detected with the 3,5-dinitrosalicylic acid reducing sugar method[@b10].

Biomass determination
---------------------

Five milliliter of sample was filtrated through Miracloth (Calbiochem, San Diego, CA, USA) to collect the hyphae and washed with distilled water. The hyphae in miracloth was heated at 105 °C until the weight did not change. For calculation of dry cell weight (DCW), the weight of Miracloth was measured previously and deducted from the total weight to generate net weight, then the net weight per unit volume was calculated as DCW.

*A. niger* cultivation and DNA preparation for genome sequencing and annotation
-------------------------------------------------------------------------------

Conidia (1 × 10^6^) were cultivated in 100 mL malt extract liquid medium (3% malt extract and 0.5% tryptone) for 2 days at 35 °C. The mycelia were harvested with Miracloth and frozen in liquid nitrogen. The genome DNA of *A. niger* was isolated with a DNeasy Plant Mini Kit (QIAGEN, Germantown, MD, USA) and subjected to quality control and library construction for genome sequencing.

Next-generation sequencing and genome assembly
----------------------------------------------

Genome sequencing of *A. niger* H915-1, L2, and A1 was performed with an Illumina Miseq 2000 system using paired-end libraries. After clean data were obtained, reads of *A. niger* A1 were assembled by using the Celera Assembler with the optimal linear combination algorithm[@b11]. The sequence data for *A. niger* A1 were deposited at DDBJ/EMBL/GenBank under the accession number LMYC00000000.

Third-generation sequencing and genome assembly
-----------------------------------------------

Genome sequencing of *A. niger* H915-1 and L2 were performed by using a PacBio RS II system with a 20-kb library. Sequences were de novo assembled with the hierarchical genome assembly process[@b12]. The longest sequencing reads were selected as a seeding sequence data set, according to which, as a reference, shorter reads were recruited and preassembled by using basic local alignment with successive refinement[@b13]. These preassembled reads were assembled by using the Celera Assembler with the optimal linear combination algorithm[@b11]. Then, the assembly was refined by using initial read data, and accuracy was improved by using Quiver[@b12]. Subsequently, minimus2 was used to connect the contigs and generate the final consensus that represented the genome[@b14]. Finally, the sequences generated by next-generation sequencing were mapped to the assembled genome for error correction by using BWA. Sequence data for *A. niger* H915-1 and L2 were deposited at DDBJ/EMBL/GenBank under the accession numbers LLBX00000000 and LKBF00000000, respectively.

Gene prediction and annotation
------------------------------

Several gene-finding software programs were used for predicting genes. AUGUSTUS[@b15], SNAP[@b16], and GeneMark + ES[@b17] were used for ab initio prediction, and Genewise[@b18] was used for homology prediction. Subsequently, EVidenceModeler was used to incorporate all of the predicted results to generate final general feature format file[@b19].

Protein sequences of all predicted genes were mapped to a non-redundant protein database (nr, National Center for Biotechnology Information), SWISS-PROT, and the TREMBLE database by using BLASTP with an E-value of 1e-5. Gene ontology (GO) annotation was performed by using interproscan-5.4-47.0 to blast to quick GO from the Interpro database. The amino acid sequences of all predicted genes were mapped to the Eukaryotic Orthologous Group and Kyoto Encyclopedia of Genes and Genomes databases by using BLASTP with an E-value of 1e-5.

Prediction of transfer RNA (tRNA) was carried out by using tRNAscan-SE 1.23, which combines several detection programs and analysis models[@b20]. Annotation of ribosomal RNA (rRNA) was finished by using RNAmmer 1.2 with hidden Markov models[@b21].

Repeat element analysis
-----------------------

Repetitive sequences were detected according to Repbase by RepeatMasker by using the default parameters[@b22]. Then, RepeatProteinMask was executed to search against the transposable element protein database to identify repeat related proteins. In addition, the tandem repeats were annotated with using the Tandem Repeats Finder program.

Prediction of ortholog group
----------------------------

Blastp was first used to generate the pairwise protein sequence with similarity of E-value less than 1e-5. Secondly, OrthoMCL was used to cluster similar genes by setting main inflation value 1.5 and other default parameters[@b23].

Variants analysis
-----------------

Single-nucleotide polymorphisms (SNPs) and insertions and deletions (indels) were detected by using SAMtools and comparing the genomes of *A. niger* L2 and A1 to *A. niger* H915-1. Then, SnpEff was used to annotate the effects of the variants[@b24]. Structural variation (SV) was detected by using Pindel.

RNA extraction and purification for RNA-seq
-------------------------------------------

Mycelia were frozen and ground under liquid nitrogen by using a mortar and pestle. RNA was isolated with an RNeasy Plant Mini Kit (QIAGEN, Germantown, MD, USA) according to the manufacturer's instructions and checked for RNA integrity by using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, US). Qualified total RNA was further purified successively with an RNeasy micro kit (QIAGEN) and RNase-Free DNase Set (QIAGEN).

Complementary DNA (cDNA) library preparation and sequencing
-----------------------------------------------------------

Purified total RNA was digested to eliminate rRNA. The RNA was then fragmented by heating at 94 °C and used to synthesize cDNA. The double-stranded cDNA was adenylated at the 3′ end, then ligated to the sequencing adapters. Pair-end sequencing was performed by using Illumina HiSeq 2500 according to the manufacturer's protocols.

Analysis of Illumina transcriptome sequencing results
-----------------------------------------------------

Raw data were filtered to remove low-quality sequences by using FASTX (version 0.0.13; <http://hannonlab.cshl.edu/fastx_toolkit/index.html>) to generate clean data. Clean reads were mapped to the genome of *A. niger* H915-1 as a reference by using TopHat (version 2.0.9)[@b25] according to the spliced mapping algorithm. The Cufflinks program (version 2.1.1)[@b26] was used to calculate unigene expression with the using FPKM method (Fragments per kb per million reads). Gene expression differences among the samples were analyzed by using Cufflinks (version 2.1.1) with a false discovery rate of ≤0.05 and a fold change of ≥2. A Perl script was used to assign a functional class to each unigene and establish pathway associations between unigenes and the Kyoto Encyclopedia of Genes and Genomes database. The sequence data have been deposited in the DDBJ/EMBL/GenBank database under the GEO accession number GSE74544.

Real-time Quantitative PCR (qPCR)
---------------------------------

For verification of transcriptome data, qPCR was performed by LightCycler 480 system (Roche, Germany) with 2 × SYBR Premix Ex Taq (Takara, Dalian, China). The primers were designed by Beacon Designer 7 and the sequences were listed in [Supplementary Table S1](#S1){ref-type="supplementary-material"}.

As the major genes of central metabolism were identified by transcriptome, these genes' expression levels of H915-1 at 48 h and A1 at 60 h were compared. The primers used were also listed in [Supplementary Table S1](#S1){ref-type="supplementary-material"}.

Construction of the gene-knockout cassette for *oah*
----------------------------------------------------

The 2.3-kb sequence upstream of *oah*, called oahA5, was cloned by using primers ([Supplementary Table S1](#S1){ref-type="supplementary-material"}) of oahA5-F and oahA5-R and the genome of *A. niger* H915-1 as a template. The 2.3-kb sequence downstream of *oah*, called oahA3, was cloned using primers of oahA3-F and oahA3-R. The sequence oahA3 was digested with *Spe* I and *Hin d*III and subsequently ligated to pAN7-1 (GenBank accession no. Z32698) and digested with *Xba* I and *Hin* dIII to construct plasmid pAN-oah3. pAN-oah3 was digested with *Xho* I and *Xba* I, ligated to the plasmid pSZH-XynB[@b27], and digested with *Xho* I and *Nde* I to construct the plasmid pSZH-oah3. pSZH-oah3 was digested with *Xba* I and *Xho* I, ligated to oahA5, and digested with *Xba* I and *Sal* I to construct the plasmid pSZH-oahA. The gene-knockout cassette of *oah* was obtained through PCR with primer oahA5-F and oahA3-R by using pSZH-oahA as a template. The primers used to validate the recombinant genome were P1, P2, P3, and P4 ([Supplementary Table S1](#S1){ref-type="supplementary-material"}).

Transformation of *A. niger*
----------------------------

Protoplast formation and transformation was performed based on a method published by Blumhoff *et al*.[@b28]. Conidia (1 × 10^8^) were cultivated in 100 mL malt extract medium for 11 h at 35 °C. The mycelium was harvested via filtration through Miracloth (Calbiochem) and washed with deionized water. Protoplastation was achieved in the presence of 5 g L^−1^ lysing enzymes from *Trichoderma harzianum* (Sigma. Saint Louis, MO, USA), 0.075 U mL^−1^ chitinase from *Streptomyces griseus* (Sigma), and 460 U mL^−1^ glucuronidase from *Helix pomatia* (Sigma) in KMC (0.7 M KCl, 50 mM CaCl~2~, 20 mM Mes/NaOH, pH 5.8) for 2 h at 37 °C and 120 rpm. Protoplastation was monitored every 30 min with a microscope. The protoplasts were filtered through Miracloth and collected via centrifugation at 2,000 × *g* and 4 °C for 10 min. The protoplasts were washed with cold STC (1.2 M sorbitol, 10 mM Tris/HCl, 50 mM CaCl~2~, pH 7.5) and subsequently resuspended in 100 μL STC and directly used for transformation. Ten micrograms of linear knock-out cassette was mixed with 100 μL STC solution containing at least 10^7^ protoplasts and 330 μL freshly prepared polyethylene glycol (PEG) solution (25% PEG 6000, 50 mM CaCl~2~, 10 mM Tris/HCl, pH 7.5) and kept on ice for 20 min. After mixing with an additional 2 mL PEG solution and incubating at room temperature for 10 min, the protoplast mixture was diluted with 4 mL STC. The aliquots were mixed with 4 mL liquid top agar warmed to 50 °C, spread on bottom agar containing 180 μg mL^−1^ hygromycin, and incubated at 35 °C for 3--6 days. All transformants were purified three times via single-colony isolation on the selection medium. The correct integration was verified with PCR analysis by using specific genomic primers. The fermentation was performed for 3 times and the data of production and yield were analyzed for the statistical significance of differences by Tukey's honestly significant difference text (T-text) using a standard package (SPSS for Windows, Version 17; SPSS Inc. Chicago, IL, USA).

Results and Discussion
======================

Citrate production by *A. niger* H915-1, L2, and A1
---------------------------------------------------

Among *A. niger* strains with different citrate production efficiencies, *A. niger* H915-1 produced the highest citrate titer of 157 g L^−1^ in 85 h, whereas *A. niger* A1 produced 117 g L^−1^ in 92 h and *A. niger* L2 produced 76 g L^−1^ in 160 h ([Fig. 1a](#f1){ref-type="fig"}). We found that during citrate fermentation, the mycelia of different strains aggregated in various forms ([Fig. 1b](#f1){ref-type="fig"}), which indicated that citrate production was influenced by the morphology of the microcolonies[@b6]. *A. niger* H915-1 formed bulbous hyphae with short, swollen hyphal branches, whereas *A. niger* A1 formed less compact pellets with less hyphal branching and longer mycelia, and *A. niger* L2 formed mycelial clumps. These differences in morphology may influence the viscosity of the medium and further affect hyphal respiration[@b29]. The tight pellet form facilitated citrate formation, and the diffused filamentous form reduced citrate production and productivity. In addition, aeration rate was an important parameter for citrate production. When aeration was maintained at 3.5 vvm, the citrate production of *A. niger* H915-1 reached 145 g L^−1^ in 72 h ([Fig. 2](#f2){ref-type="fig"}).

General genome statistics and differences among the three strains
-----------------------------------------------------------------

Three *A. niger* strains (H915-1, A1, and L2) capable of gradient citrate production were selected for genome sequencing. The genome sequences of *A. niger* H915-1 and L2 were obtained with a PacBio RS II system, and *A. niger* A1 was sequenced by using whole-genome shotgun paired-end sequencing. Sequences of *A. niger* H915-1 and L2 were further improved to high-quality assemblies of 30 finished contigs ([Table 1](#t1){ref-type="table"}). The assembled genome of *A. niger* A1 consisted of 319 contigs. The genome sizes of *A. niger* H915-1, L2, and A1 were 35.98 Mb, 36.45 Mb, and 34.64 Mb, respectively, and the number of predicted genes ranged from 10,123 to 10,433---approximately 26% smaller than *A. niger* CBS 513.88 and 10% smaller than *A. niger* SH2, both of which are enzyme production strains. The number of tRNA in *A. niger* H915-1 and L2 were more than 2-fold those of *A. niger* A1, CBS 513.88, and SH2. To investigate the reason of dramatic changes on tRNA number, the genome of H915-1 was assembled either de novo or using LLBX00000000 as reference only with the "next-generation" sequencing data. The de novo assembly genome was 35.5 M with 255 tRNA, and the genome assembled using LLBX00000000 as reference was 36.0 M with 667 tRNA, indicating that the problem of losing information by second-generation sequencing was not significant, but the assembly method influenced the genome result a lot and also the "next-generation" sequencing with different read lengths was importance for rectify assembly results[@b30][@b31]. The ortholog names was provided in [Supplementary Table S2](#S1){ref-type="supplementary-material"} for matching gene ID of H915-1 to gene ID of CBS513.88.

The Clusters of Orthologous Groups (COG) is a database where the orthologous gene products were classified. We searched the annotated sequences for the genes involved in COG classifications and more than 3,700 sequences had a COG classification. Compared with strain L2 and A1, there are more genes belonging to categories A (RNA processing and modification), C (Energy production and conversion), F (Nucleotide transport and metabolism), G (Carbohydrate transport and metabolism) and S (Intracellular trafficking, secretion, and vesicular transport) in strain H915-1 ([Supplementary Table S3](#S1){ref-type="supplementary-material"}). The three strains shared 9097 gene groups ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}). Compared with *A. niger* L2 and A1, *A. niger* H915-1 contained only 1 unique gene group and lacked 58 groups of genes ([Supplementary Table S4](#S1){ref-type="supplementary-material"}). Syntenic dot plot analysis of the three experimental strains and *A. niger* CBS 513.88 ([Fig. 3](#f3){ref-type="fig"}) and extensive structural reorganizations were observed. When compared to genome of H915-1 as reference, the genome of L2 and A1 contained 1210 SNP/indel and 52 SVs, within which existed 57 non-synonymous SNPs ([Supplementary Tables S5 and S6](#S1){ref-type="supplementary-material"}) and 35 SVs involving gene mutation ([Supplementary Table S7](#S1){ref-type="supplementary-material"}).

For the genes mutated in strains of A1 and L2, the most notable was a succinate-semialdehyde dehydrogenase involved in γ-aminobutyric acid (GABA) shunt pathway for succinate supplement in TCA cycle, indicating that metabolite flux was modulated for citrate production. Also, a mutation was found in an aconitase family protein, which could relate to the production of citrate. Furthermore, mutations of a proline utilization trans-activator and a branched-chain-amino-acid aminotransferase indicated amino acid metabolism may relate to citrate synthesis. The synthesis of amino acids were started from organic acids in glycolysis and TCA cycle. Pyruvate, 3-phospho-D-glycerate, oxaloacetate and 2-oxoglutarate were all precursors of amino acids, as a result, amino acids synthesis pathway could drain metabolites used in organic acids synthesis. In addition, SVs were found in 60S ribosomal protein L5 relevant for mediating 5S rRNA binding[@b32], DNA repair protein, DNA-directed RNA polymerase II subunit, RNA-splicing protein and mRNA transport regulator, suggesting changes on cell viability. As citrate is a primary metabolite for *A. niger*, the production of citrate may associate with the vegetative growth rate.

For citrate fermentation of *A. niger*, the morphological development was considered to start with the aggregation of conidia right after inoculation, then the conidia begun to germinate and formed mycelium[@b33][@b34]. The pathways for formation of hydrophobin and melanin ([Supplementary Table S8](#S1){ref-type="supplementary-material"}), which induced conidia aggregation and subsequent germ tube aggregation[@b34][@b35][@b36] had no differences, though the 3 strains showed different morphology of micro-colonies. Fungal cell wall consists of 80--90% polysaccharides, and most of the remainders are protein and lipid[@b37]. The functions of these diverse cell wall proteins included defense response[@b38], maintaining cell surface hydrophobicity[@b39], and regulation of morphogenesis[@b40]. The cell wall protein *lrx1* mutated *Arabidopsis thaliana* developed swell and branch root hairs[@b40]. In this study, a cell wall protein lacked in H915-1, and there existed the possibility to influence the cell morphology.

Transcriptome analysis of H915-1 during citrate production
----------------------------------------------------------

To obtain a general picture of *A. niger* cell physiology during citrate production, we studied the transcriptome of H915-1 during this process in a 3-L fermenter. In the case that aeration was maintained at 3.5 vvm, hyphae were sampled at 6 h, 12 h, 24 h, 36 h and 48 h. When fermented for 6 h, the medium pH dropped from 4.8 to 3.5, and the hyphae were still at growing age and citrate productivity was slow at 0.66 g L^−1^ h^−1^. Subsequently, citrate productivity increased to 2.34 g L^−1^ h^−1^, 3.26 g L^−1^ h^−1^, 2.75 g L^−1^ h^−1^, and 1.94 g L^−1^ h^−1^ at 12 h, 24 h, 36 h, and 48 h, respectively ([Fig. 2](#f2){ref-type="fig"}).

Compared with expression at the cell growth stage (6 h), the expression of 479 of 9953 genes changed at all 4 time points during the citrate synthesis stage (12 h, 24 h, 36 h, and 48 h): 269 genes showed increased expression levels, and 210 genes were down-regulated (fold change ≥ 2 and false discovery rate ≤ 0.05). These results identified the key genes for citrate production. In addition, the number of differentially expressed genes increased with fermentation time ([Fig. 4a](#f4){ref-type="fig"}), which indicated a strong cellular response to the changing conditions of citrate secretion.

For verification of the transcriptome data, the fermentation was repeated and sampled at the same time as that for transcriptome analysis. Several genes including genes in central metabolism and 2 other genes (evm.model.1.1208 and evm.model.unitig_3.181), which increased greatly during fermentation, were analyzed by qPCR and the fold change of gene expression level was compared with that of the transcriptome data ([Supplementary Figure 2](#S1){ref-type="supplementary-material"}). The result showed similar trend by qPCR and transcriptome analysis. The expression level of evm.model.1.1208 and evm.model.unitig_3.181 all increased by similar folds at 12, 24, 36 and 48 h compared to 6 h in both experiments, and the expression level of genes in central metabolism were also up-regulated/down-regulated at similar levels in both experiments, confirming the result of transcriptome analysis.

Regulation of central metabolism (glycolysis, TCA cycle, rTCA cycle and GABA shunt pathway) for citrate production
------------------------------------------------------------------------------------------------------------------

Citrate is formed mainly via cytosolic glycolysis and the subsequent mitochondrial TCA cycle. The expression levels of genes involved in glycolysis were mostly unaffected, but many genes involved in the TCA cycle were down-regulated ([Fig. 4b](#f4){ref-type="fig"}, [Table 2](#t2){ref-type="table"}). Six isoenzymes catalyze glucose phosphorylation in *A. niger* H915-1. Of these, 5 isoenzymes are hexokinases, the transcription levels of which did not change noticeably. Hexokinase activity was non-competitively inhibited by citrate[@b41], and to compensate for metabolite flux, the expression level of glucokinase was up-regulated gradually during citrate production ([Fig. 5a](#f5){ref-type="fig"}).

A triosephosphate isomerase was up-regulated 2-fold during citrate production. Because 1 mol [d]{.smallcaps}-fructose 1,6-bisphosphate decomposed into 1 mol dihydroxyacetone phosphate and 1 mol [d]{.smallcaps}-glyceraldehyde 3-phosphate, only [d]{.smallcaps}-glyceraldehyde 3-phosphate remained as the substrate for the next enzyme in glycolysis. The triosephosphate isomerase must be up-regulated to form additional [d]{.smallcaps}-glyceraldehyde 3-phosphate.

Phosphofructokinase (PFK1) was another key regulator in glycolysis. The expression level of PFK1 changed only slightly. PFK1 was inactivated by high concentrations of citrate, ATP, and manganese; however, the inhibition can be antagonized by NH~4~^+^ ions and fructose-2,6-bisphosphate[@b42].

After glucose is catabolized to pyruvate, a part of the pyruvate is transported into the mitochondria to form acetyl-coenzyme A (acetyl-CoA), which was the substrate of citrate synthase. There are 2 mitochondrial citrate synthases, all of which were down-regulated. The convesion rate of citrate did not seem to be a rate-limiting step for citrate production, and flux in citrate synthesis stage might even be reduced compared to that at 6 h.

The reactions that followed citrate synthase in the TCA cycle were all down-regulated at the transcription level. Among 4 predicted aconitases, 2 mitochondrial enzymes were highly transcribed and their expression levels decreased. Of the 3 isocitrate dehydrogenases in *A. niger* H915-1, the cytosolic NADP^+^-dependent form and 1 mitochondrial NAD^+^-dependent form were down-regulated.

2-Oxoglutarate (KGA) dehydrogenase was repressed at both the transcriptional level and the post-translation level[@b6], and the GABA shunt pathway was up-regulated for succinate acid supplementation. KGA and GABA were catalyzed to produce succinate semialdehyde, which was further transformed to succinate. This situation is identical to that observed in *A. niger* CBS 513.88, which depends completely on the alternative respiration pathway because the succinate-CoA ligase complex is absent during fermentation according to transcription data[@b4]. This pathway is also important for KGA production in *Yarrowia lipolytica*[@b43].

The intermediate glutamate enhances acid tolerance by consuming intracellular protons via amino acid decarboxylation, which helps increase intracellular pH[@b44][@b45]. The pathway is also involved in the release of NH~4~^+^ ions into the cytosol, which antagonizes citrate inhibition of phosphofructokinase[@b6].

The oxaloacetate was formed either from TCA cycle or rTCA cycle. The former way lose two moles of carbon dioxide, while the latter way associated with fixing CO~2~ to pyruvate by pyruvate carboxylase to form oxaloacetic acid (OAA), which is subsequently reduced to malate by malate dehydrogenase and enters the mitochondria via a malate-citrate antiporter. Subsequently, malate participates in the TCA cycle and forms citrate. *A. niger* H915-1 contained 2 genes for pyruvate carboxylase, and only the cytosolic gene was observed to be transcribed. This gene was down-regulated dramatically to one-third the level observed at 6 h compared with citrate-synthesis-stage. For the 3 cytosolic malate dehydrogenases, only one was dramatically transcribed during fermentation, and malate dehydrogenase located in the mitochondrion was down-regulated.

Most of the genes in central metabolism were reported to be down regulated during citrate fermentation compared to cell-growing-phase, and the explanation for this situation was that as the broth pH decreased to extreme low level, the basic cell metabolism was down regulated for response of low pH. Though the expression was down-regulated, the expression level of FPKM was still high for citrate formation. The noticeable high metabolism during cell-growing-phase was reasonable because the cell weight was increased dramatically during the first 12 h ([Fig. 2](#f2){ref-type="fig"}). As the major genes of central metabolism were identified, the genes expression level of strain A1 at 60 h was analyzed by qPCR compared to H915-1 at 48 h ([Fig. 5b](#f5){ref-type="fig"}) and most of the genes were depressed in A1, indicating the higher genes expression level was responsible for higher citrate production.

Up-regulation of ATP-citrate lyases coordinate with the alternative respiratory pathway for energy balance
----------------------------------------------------------------------------------------------------------

During citrate fermentation, energy balance was important because the conversion of citrate from glucose generated 1 mol ATP and 3 molecules of NADH, which was redundant and needed to be consumed[@b46]. The alternative pathway took charge of oxidizing excess NADH without forming ATP and the alternative oxidase was the core enzyme in the pathway[@b47]. In this study, the expression of alternative oxidase was mostly up-regulated at citrate-synthesis-phase compared to cell-growing-phase, confirming the importance of the pathway for citrate fermentation[@b8]. Nevertheless, the expression levels of alternative oxidase were low compared to other major genes of central metabolism, indicating that the other pathway for ATP consumption may be needed to help balance the energy. Notably, 2 cytosolic ATP-citrate lyases were up-regulated, which took part in a futile cycle. The mitochondrial citrate was transported to the cytoplasm, most of which was transported outside the cell and a small amount was catalyzed to generate OAA by ATP-citrate lyase with ATP consumption. Subsequently, OAA was transformed to malate and resupplied for mitochondrial citrate formation. This cycle consumed 1 mol ATP and the up-regulation of 2 cytosolic ATP-citrate lyases indicated that the pathway may help releaseing the pressure of the alternative respiration pathway for the recycling of NADH.

Regulation of heteroacid formation genes
----------------------------------------

*A. niger* strives to produce - at a given pH - the organic acid that most efficiently acidifies the medium. *A. niger* can produce several organic acids, including gluconate, oxalate, lactate, malate, succinate, and citrate[@b48]. Gluconate and oxalate are the main heteroacids that affect citrate production under certain conditions[@b49]. The secretion of heteroacid acids helps to decrease medium pH to below 3.0, which is crucial for citrate production[@b6][@b48], and after citrate formation was triggered, the major role for acidification the medium was played by citrate. The expression profiles of genes involved in the formation of the primary heteroacids are shown in [Supplementary Table S9](#S1){ref-type="supplementary-material"}.

The oxaloacetate acetylhydrolase (evm.model.unitig_6.59) catalyzed the degradation of oxaloacetate to form oxalate and acetate. The *oah* gene was highly expressed at 6 h of fermentation, which was in agreement with the report by Ruijter *et al*. (1999) that oxalate is the preferred acid in a strain capable of producing organic acids, and in Andersen's stoichiometric model of *A. niger* metabolism, that the simulations predicted oxalate as the only produced organic acid throughout the pH range from 1.5 to 6.5[@b48].

Subsequently, the expression of *oah* gene was depressed and oxalate decarboxylase (evm.model.1.1180) was expressed at a constitutively high level during the citrate production period, thereby guaranteeing the elimination of oxalate after citrate begun to form and citrate became the major acid in the medium, and the situation also agreed with the Andersen's stoichiometric model that citrate is the optimal acid for medium acidification when oxalate cannot be produced when pH ranged from 1.5 to 2.5[@b48]. The reason of the trait remains obscure, but it may be an evolutionary strategy and one of the hypotheses suggests that low pH helps degrade plant cell walls, facilitating saprotrophic living of fungus, that it inhibits the growth of competing organisms, and that the acids chelate trace metals, making them available to the fungus[@b50].

At the same time of oxalic acid formation, the same amount of acetate was produced in cytosol by oxaloacetate hydrolase. In addition, high expression level of acetyl-CoA hydrolase (evm.model.unitig_6.429) at 6 h further increased the acetate synthesis in *A. niger*. Nevertheless, acetate accumulation did not occur in the medium, suggesting the catabolic rate of acetate was sufficient to prevent its formation as Ruijter *et al*. (1999) reported. The result was also in agreement with the simulations predict by Andersen *et al*. (2009) that it is more energetically efficient to re-metabolize acetate than to use it for acidification of the medium. However, in the later fermentation phase, the expression levels of both oxaloacetate acetylhydrolase and acetyl-CoA hydrolase were dramatically down-regulated, indicating the decrease of acetate pathway and a main metabolite flux into the TCA cycle for citrate production.

*A. niger* H915-1 had only 1 glucose oxidase (evm.model.unitig_0.36), which was an extracellular enzyme and catalyzed the formation of gluconic acid from glucose in broth. The enzyme was only expressed during the early stage of fermentation but silent later. This result was in agreement with the report that gluconic acid is an early product during citrate fermentation[@b51]. In addition, the enzyme was inactivated at pH values below 3.5, and this further guaranteed the elimination of gluconic acid formation when producing citrate[@b6].

Regulation of transporters
--------------------------

Elucidating the transport of both sugars and citrate is crucial to understanding citrate overproduction by *A. niger*. However, disagreement exists about the mechanisms underlying both the uptake of glucose and the secretion of citrate ions. Overall, 46 transporters were expressed differently at the transcriptional level during citrate production ([Table 3](#t3){ref-type="table"}).

Both simple diffusion and sugar transporters were found responding for glucose uptake during citrate producing[@b52][@b53][@b54]. In this study, 28 sugar transporters were expressed, among which a low-affinity glucose transporter (evm.model.unitig_0.1567) was constitutively expressed during fermentation at high level, and 5 high-affinity glucose transporters were expressed constitutively at low level, and a hexose transporter was up-regulated. The result supported the suggestion that a low-affinity glucose transporter has a major function in glucose catabolism among all sugar transporters[@b55]. Nevertheless, the low-affinity glucose transporter was formed when grown on a high (15% w/v) glucose concentration in previous report[@b55], but in this work, the transporter could be constitutively expressed during citrate fermentation even at 48 h when the glucose concentration decreased to 8%. Furthermore, the roles of high-affinity glucose transporters could be confirmed as glucose can be consumed entirely in late stage[@b6].

The mechanism for citrate transportation through the plasma membrane requires further study. Because a dramatic pH gradient exists between the plasma and the extracellular medium, citrate is produced mainly as citrate^2−^ in the cytosol (with a pH between 6.0 and 7.0) and as an undissociated form of acid in medium (with a pH below 2.0)[@b56]. Citrate^2−^ can be secreted from *A. niger* into broth, and the hyphae can take up citrate at the end of citrate fermentation, which indicates that both of the 2 forms of citrate can cross the cell wall. Nevertheless, no citrate transporter has yet been identified. In this study, 35 transporters were identified as being up-regulated during citrate fermentation, among which 3 organic anion transporters, a low-affinity iron transporter, and a monocarboxylate transporter were found. In addition, the transcription levels of 11 uncharacterized transporters increased. These transporters constituted candidate citrate transporters.

Regulation of genes involving cell wall components
--------------------------------------------------

The main cell wall of *A. niger* contains β-1, 3-glucan, chitin, β-1, 6-glucan, α-1, 3-glucan, galactosaminogalactan, and galactomannan[@b57]. We found that expression levels of several genes involved in cell wall integrity were up-regulated during citrate production ([Supplementary Table S10](#S1){ref-type="supplementary-material"}). Chitin synthase C was highly up-regulated. Pst1 was previously identified as a cell surface glycosylphosphatidylinositol-anchored protein important for cell wall integrity[@b58][@b59] and the expression of *PST1* increased during fermentation, helping maintain cell wall strength for resistance to the low pH of the medium. The α-1,3-glucan usually exists on the cell wall of conidia and glues melanin to the conidial surface[@b60], and it also plays an essential role in the aggregation of conidia[@b61][@b62]. The expression of alpha-1, 3-glucan synthase ags1 was up-regulated during citrate fermentation, which indicated that it might also play a role in the aggregation of hypha. In addition, UDP-*N*-acetylglucosaminyltransferase and *N*-acetylglucosaminidase were both up-regulated, which indicated the synthesis of various types of glycoproteins and *N*-glycans[@b63]. Furthermore, 3 endoglucanases were down-regulated to reduce cell wall degradation.

Elimination of oxalate formation and increased citrate production through deletion of *oah* in *A. niger*
---------------------------------------------------------------------------------------------------------

*A. niger* H915-1 expressed *oah* dramatically and resulted in oxalate synthesis early in the fermentation process. The role of oxalate on citrate production still needed to be confirmed. The production of oxalate may facilitated the acidification of medium and guarantee a low pH for citrate fermentation. However, the synthesis of oxalate may drain metabolites used for cell growth and influence subsequent citrate fermentation. As a result, the *oah* gene was knocked out to examine its role in citrate fermentation.

We obtained an *oah* gene deletion strain ([Fig. 6a](#f6){ref-type="fig"} and b) and found that when the length of the flanking DNA reached 2.3 kb, the homologous recombination rate was 65%. During citrate fermentation in *A. niger* H915-1, oxalate was synthesized earlier than citrate and then eliminated later in the fermentation phase. When *oah* was deleted, the strain no longer synthesized oxalate ([Fig. 6c](#f6){ref-type="fig"}). The pH during fermentation between H915-1 and H915 (*Δoah::hph*) was not different, indicating that though oxalate production had impact on pH decrease, it was not the decisive factor due to diverse organic acids synthesized by *A. niger*. In addition, the deletion of *oah* in H915-1 did not influence the biomass either, suggesting the extremely high expression of *oah* drained little flux from cell growth, which was the same with the phenomenon of oah-deleting *A. niger* strain for enzyme production[@b64]. Finally, the influence of citrate production through the deletion of *oah* was not significant. Though the citrate yield was up-regulated by 1.7% ([Supplementary Table S11](#S1){ref-type="supplementary-material"}), the difference was not statistical significant by t-test.

Conclusion
==========

The genome of industrial citrate-producing *A. niger* strain H915-1 was sequenced and compared with genomes of 2 strains that produce citrate at lower levels. SNP analysis revealed differences at 57 sites and 35 SVs in various genes in the *A. niger* H915-1 genome. These genes were involved in the TCA cycle, GABA shunt pathway, and other pathways. Transcriptome analysis of *A. niger* H915-1 during citrate fermentation showed that among the genes expressed during the cell growth stage (6 h), 479 genes were expressed differently at all 4 time-points of the citrate production stage (12 h, 24 h, 36 h, and 48 h). The data showed the expression profile of the major genes in the involved pathways. The up-regulation of ATP-citrate synthase may coordinate with the alternative respiratory pathway for energy balance. Furthermore, 35 transporters were up-regulated, which identified previously unknown candidate citrate transporters. In addition, to solve the problems of abundantly expressed *oah* and oxalate formation during the early phase of fermentation, we knocked out *oah* in *A. niger* H915-1, which neither affected citrate production nor influenced acidification of medium. The results of this study revealed the mechanism of citrate production in *A. niger* and contribute to future rational metabolic design.
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![Citrate fermentation of different *A. niger* strains.\
(**a**) Citrate titer and fermentation time. Δ, citrate production. □, concentration of reducing sugar. ○, pH. (**b**) Morphology of different strains. Bar represents 40 μm. Black arrow pointed to a conidium.](srep41040-f1){#f1}

![Fed-batch culture of *A. niger* H915-1 for citrate production.\
Aeration was maintained at 3.5 vvm. Sample time was shown in red arrows. ▲, citrate production. ■, concentration of reducing sugar. ○, pH. ◊, DCW.](srep41040-f2){#f2}

![Syntenic dot plot of *A. niger* H915, *A. niger* L2 and *A. niger* A1 with *A. niger* CBS 513.88.\
(**a**) *A. niger* H915. (**b**) *A. niger* L2. (**c**) *A. niger* A1.](srep41040-f3){#f3}

![Transcriptional profile during citrate fermentation.\
(**a**) Number of differentially expressed genes during fermentation. (**b**) Expression profile of genes in glycolysis and TCA cycle.](srep41040-f4){#f4}

![Transcription level regulation of genes in central metabolism.\
(**a**) Transcription level regulation of genes in glycolysis and TCA cycle of H915-1 during citrate production. Red ellipse means up-regulated genes. Green ellipse means down-regulated genes. Half blank ellipse means that expression levels of some isoenzymes were not changed, while the other isoenzymes were affected. Abbreviations: GABA, 4-aminobutanoate; AC, acetate; AcA, acetaldehyde; AcCoA, acetyl-CoA; Aco, cis-aconitate; AOX1, alternative oxidase; CA, citrate; F-1,6--2P, fructose 1,6-bisphosphate; ETH, ethonal; F-6-P, fructose 6-phosphate; FA, fumarate; FMA, formate; G-6-P, Glucose 6-phosphate; Ga-3-P, glyceraldehyde 3-phosphate; GAA, glutamate; Glu, glucose; GI-1,3--2P, 3-phospho-D-glyceroyl phosphate; GI-2-P, 2-phospho-D-glycerate; GI-3-P, 3-phospho-D-glycerate; GIP, dihydroxyacetone phosphate; GOA, glyoxylate; ICA, isocitrate; KGA, 2-oxoglutarate; MA, malate; OA, oxalate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; Pyr, pyruvate; SA, succinate; SSA, succinate semialdehyde; SuCoA, succinyl-CoA. (**b**) qPCR of gene expression fold changes of A1 at 60 h compared to H915-1 at 48 h. Error bars represent three technical replicates.](srep41040-f5){#f5}

![Deletion of *oah* in *A. niger* resulted in oxalate eliminated and slightly increased citrate production yield.\
(**a**) A graphical representation showing gene deletion of *oah* in *A. niger* and primers used for validation of recombinated genome. (**b**) PCR products of the sequences down-stream of *oah* using primers P3 and P4 (upper) and *oah* gene using primers P1 and P2 (below). Lane 1--20, *A. niger* transformants; Lane CK, wild type of H915-1; Lane M, DNA ladder. (**c**) Citrate and oxalate production of H915-1 and H915 (*Δ*oah::hph).](srep41040-f6){#f6}

###### General features of genomes of *A. niger* H915-1, L2 and A1.

                                  *A. niger* H915   *A. niger* L2   *A. niger* A1
  ------------------------------ ----------------- --------------- ---------------
  Genome size (Mb)                     35.98            36.45           34.64
  Contigs                               30               30              319
  N50 (bp)                           4,441,427        4,157,665        247,692
  Sequencing depth                     88.05            88.07            83
  Gene models                         10,318           10,433           10123
  Protein length (amino acids)          498              501             498
  Exons per gene                         3                3               3
  Average gene length (bp)             1,787            1,781           1,756
  Number of tRNA                        666              557             278

###### Transcription levels of genes involving glucose metabolism during citrate fermentation.

  EC number     gene ID                                               Gene function                                                FPKM-6h    FPKM-12h   FPKM-24h   FPKM-36h   FPKM-48h
  ------------- ----------------------------------------------------- ----------------------------------------------------------- ---------- ---------- ---------- ---------- ----------
  EC 2.7.1.1    evm.model.unitig_0.782                                hexokinase                                                   335.407    263.428    264.615    398.452    396.328
  EC 2.7.1.1    evm.model.unitig_1.1360                               hexokinase                                                   0.799634   0.518701   0.376546   0.25131    0.219428
  EC 2.7.1.1    evm.model.unitig_2.1160                               hexokinase family protein XprF                                12.973    13.2989    12.8881    18.8512    14.8755
  EC 2.7.1.1    evm.model.unitig_4.158                                hexokinase family protein                                    49.2115    49.5622    61.4378    65.9747    75.2536
  EC 2.7.1.1    evm.model.unitig_6.819                                hexokinase-1                                                 19.7688    20.2945    25.5583    24.9562     25.509
  EC 2.7.1.2    evm.model.unitig_4.1015                               glucokinase                                                  127.778    150.188     203.7     242.765    250.044
  EC 5.4.2.2    evm.model.unitig_0.1273                               phosphoglucomutase                                           92.2402    108.093    119.862    216.005    192.424
  EC 5.4.2.2    evm.model.unitig_0.474                                phosphoglucomutase                                           45.8516    54.1326    57.7454    77.0618    68.9388
  EC 5.3.1.9    evm.model.unitig_6.538                                glucose-6-phosphate isomerase                                 185.76    83.2219    101.433     153.62    149.017
  EC 2.7.1.11   evm.model.unitig_1.93                                 phosphofructokinase                                          332.854    231.523    273.895    381.057    321.602
  EC 3.1.3.11   evm.model.1.362                                       fructose-1,6-bisphosphatase                                  185.489    126.953    103.246    196.543    215.136
  EC 4.1.2.13   evm.model.unitig_0.1289                               fructose-bisphosphate aldolase                                1415.9     608.32    742.795    1381.51    1233.53
  EC 4.1.2.13   evm.model.unitig_5.221                                fructose-bisphosphate aldolase                               4.14539    3.74066    2.58741    7.12841    6.59831
  EC 5.3.1.1    evm.model.unitig_5.192                                triosephosphate isomerase                                    781.339    500.828    658.134    1048.47    1070.47
  EC 5.3.1.1    evm.model.unitig_0.1612                               triosephosphate isomerase                                    99.5623    205.847    190.824    264.163    351.897
  EC 1.2.1.12   evm.model.unitig_4.875                                glyceraldehyde-3-phosphate dehydrogenase                     289.264    257.795    158.841    222.297    289.137
  EC 1.2.1.12   evm.model.unitig_6.799                                glyceraldehyde-3-phosphate dehydrogenase                     2149.06    1463.62    1729.79    2551.67    2242.18
  EC 2.7.2.3    evm.model.unitig_1.643                                phosphoglycerate kinase                                      1092.79    558.191    673.403    922.674    866.895
  EC 5.4.2.1    evm.model.unitig_6.503                                phosphoglycerate mutase                                      95.5362    36.1718     64.161    84.4621    65.0384
  EC 5.4.2.1    evm.model.unitig_6.710                                phosphoglycerate mutase                                      769.017     423.86    524.205    666.103    634.037
  EC 4.2.1.11   evm.model.unitig_6.540                                enolase                                                      60.0857    45.7904    43.6861    57.3401    76.4556
  EC 4.2.1.11   evm.model.unitig_1.422                                enolase                                                       1916.1    1019.34    1313.81    1840.59    1892.42
  EC 2.7.1.40   evm.model.unitig_0.620                                pyruvate kinase                                              1765.16     838.18    840.933    959.252    922.378
                                                                      **tricarboxylic acid cycle**                                                                                 
  EC 2.3.1.12   evm.model.unitig_0.153[\*](#t2-fn1){ref-type="fn"}    dihydrolipoyllysine-residue acetyltransferase                496.018    402.791    346.071    317.373    227.624
  EC 1.2.4.1    evm.model.unitig_0.667[\*](#t2-fn1){ref-type="fn"}    pyruvate dehydrogenase E1 component subunit alpha             297.87    261.578    236.515    237.141    162.256
  EC 1.2.4.1    evm.model.unitig_2.1112[\*](#t2-fn1){ref-type="fn"}   pyruvate dehydrogenase E1 component subunit beta             219.671    169.985    139.605    155.358     124.71
  EC 1.2.4.1    evm.model.unitig_3.851                                pyruvate dehydrogenase E1 component subunit alpha            13.0844    9.68933    14.6326    11.1757    15.6863
  EC 1.8.1.4    evm.model.unitig_0.477[\*](#t2-fn1){ref-type="fn"}    dihydrolipoyl dehydrogenase                                  137.583    104.234    95.4635    111.925    88.9546
  EC 2.3.3.1    evm.model.unitig_4.422[\*](#t2-fn1){ref-type="fn"}    citrate synthase                                             887.236     277.72    153.559    146.579    146.101
  EC 2.3.3.1    evm.model.unitig_5.597[\*](#t2-fn1){ref-type="fn"}    citrate synthase                                             1783.01    918.481    542.466     513.1     486.779
  EC 2.3.3.1    evm.model.unitig_1.1397                               citrate synthase                                             166.357    13.8929    5.34897    9.72465    6.61541
  EC 2.3.3.1    evm.model.unitig_5.827                                citrate synthase                                             55.1809    8.74314    38.5607    12.3544    26.6205
  EC 2.3.3.1    evm.model.unitig_2.384                                citrate synthase                                             2.52289    3.07562    36.8849    10.2526    29.7107
  EC 2.3.3.8    evm.model.unitig_3.1144                               ATP-citrate synthase subunit 2                               17.2562     71.315    67.7677    118.432    94.7237
  EC 2.3.3.8    evm.model.unitig_3.1145                               ATP-citrate synthase subunit 1                               28.8278    94.1346    80.0228    159.645     118.98
  EC 4.1.3.6    evm.model.unitig_2.489[\*](#t2-fn1){ref-type="fn"}    citrate lyase beta subunit                                   36.8118    26.2511    17.9149    15.3349    14.9401
  EC 4.2.1.3    evm.model.unitig_1.1226[\*](#t2-fn1){ref-type="fn"}   aconitate hydratase                                          896.845    720.406    447.551     601.52    551.053
  EC 4.2.1.3    evm.model.unitig_5.803[\*](#t2-fn1){ref-type="fn"}    aconitate hydratase                                          69.8504     41.158    39.9385    40.9545    29.8112
  EC 4.2.1.3    evm.model.unitig_0.1022                               aconitase                                                    0.05719       0       0.219753   0.054301      0
  EC 4.2.1.3    evm.model.unitig_6.517                                aconitate hydratase                                           3.2308    1.44962    1.23429    2.01631    1.53043
  EC 1.1.1.41   evm.model.unitig_1.461[\*](#t2-fn1){ref-type="fn"}    isocitrate dehydrogenase (NAD^+^) subunit 1                  651.892    397.868     316.08    238.206    261.487
  EC 1.1.1.41   evm.model.unitig_1.881[\*](#t2-fn1){ref-type="fn"}    isocitrate dehydrogenase (NAD^+^) subunit 2                  117.139    91.5155    77.0455    74.0661    66.8811
  EC 1.1.1.42   evm.model.unitig_0.935                                isocitrate dehydrogenase (NADP^+^)                           379.561    55.4311     53.793     43.56     36.8787
  EC 1.2.4.2    evm.model.1.395[\*](#t2-fn1){ref-type="fn"}           2-oxoglutarate dehydrogenase E1                               123.4     101.134    68.2161    101.575    82.1217
  EC 1.2.4.2    evm.model.unitig_1.1359[\*](#t2-fn1){ref-type="fn"}   2-oxoglutarate dehydrogenase                                 0.175744      0       0.082844      0       0.146153
  EC 2.3.1.61   evm.model.unitig_3.373[\*](#t2-fn1){ref-type="fn"}    dihydrolipoyllysine-residue succinyltransferase              906.116    585.033    461.624     440.09    430.991
  EC 1.8.1.4    evm.model.unitig_0.477[\*](#t2-fn1){ref-type="fn"}    dihydrolipoamide dehydrogenase                               137.583    104.234    95.4635    111.925    88.9546
  EC 6.2.1.4    evm.model.unitig_1.691[\*](#t2-fn1){ref-type="fn"}    Succinyl-CoA synthetase subunit alpha                        10.1584    8.35142    10.9483    6.28717    6.26733
  EC 6.2.1.4    evm.model.unitig_6.212[\*](#t2-fn1){ref-type="fn"}    succinyl-CoA ligase (GDP-forming) subunit alpha               167.72    151.294    152.653    134.668    143.569
  EC 6.2.1.5    evm.model.unitig_5.547[\*](#t2-fn1){ref-type="fn"}    succinyl-CoA ligase (GDP-forming) subunit beta               187.764    164.558    147.869    139.546    136.451
  EC 1.3.5.1    evm.model.unitig_0.1278[\*](#t2-fn1){ref-type="fn"}   succinate dehydrogenase (ubiquinone) flavoprotein subunit    24.5134    26.5336     25.821     34.938    34.3454
  EC 1.3.5.1    evm.model.unitig_5.222[\*](#t2-fn1){ref-type="fn"}    succinate dehydrogenase (ubiquinone) flavoprotein subunit    106.025    80.5352    64.0832    82.0902    49.7971
  EC 1.3.5.1    evm.model.unitig_0.912[\*](#t2-fn1){ref-type="fn"}    succinate dehydrogenase (ubiquinone) flavoprotein subunit    300.998    183.431    129.831    141.769    117.838
  EC 4.2.1.2    evm.model.unitig_4.976[\*](#t2-fn1){ref-type="fn"}    fumarate hydratase                                           216.899    165.403     133.22    129.303    125.578
                                                                      **malate supplementary pathway**                                                                             
  EC 1.1.1.37   evm.model.unitig_0.152[\*](#t2-fn1){ref-type="fn"}    malate dehydrogenase                                         382.681    178.625    166.671    194.694    144.212
  EC 1.1.1.37   evm.model.unitig_4.581                                malate dehydrogenase                                         1180.59    937.119    1049.38    1328.52      1438
  EC 1.1.1.37   evm.model.unitig_3.674                                malate dehydrogenase                                            0          0          0          0          0
  EC 1.1.1.37   evm.model.unitig_0.1439                               malate dehydrogenase                                            0       0.733162   0.69599    1.80872    1.30924
  EC 6.4.1.1    evm.model.1.596                                       pyruvate carboxylase                                         1072.72    247.724     344.37    407.141    385.564
  EC 6.4.1.1    evm.model.unitig_4.358[\*](#t2-fn1){ref-type="fn"}    pyruvate carboxylase                                         3.10673    2.89939    1.60237    1.91294    1.46637
                                                                      **Alternative aeration**                                                                                     
  EC 1.6.5.9    evm.model.unitig_1.793                                alternative NADH-ubiquinone oxidoreductase                   22.4626     16.162    23.7158    14.4778    12.7033
                evm.model.unitig_3.600                                alternative oxidase                                             0       0.287791      0       0.27723    0.237374
                evm.model.unitig_3.832                                alternative oxidase                                          29.5249     76.824    27.4381    99.4477    54.1134
                                                                      **Glyoxylate cycle**                                                                                         
  EC 2.3.3.9    evm.model.unitig_4.427                                malate synthase, glyoxysomal                                 144.411    152.274    43.8047    93.8427    68.3562
  EC 4.1.3.1    evm.model.unitig_2.434                                isocitrate lyase                                             1912.74    277.935    41.5601    47.8565    114.906
  EC 4.1.3.1    evm.model.unitig_4.958[\*](#t2-fn1){ref-type="fn"}    isocitrate lyase                                             450.798    136.445    121.203    118.647    160.556
                                                                      **GABA shunt pathway**                                                                                       
  EC 2.6.1.19   evm.model.unitig_6.167[\*](#t2-fn1){ref-type="fn"}    4-aminobutyrate aminotransferase                             44.1905    92.7175    120.197    163.909    105.917
  EC 1.2.1.16   evm.model.1.554                                       succinate-semialdehyde dehydrogenase (NADP^+^)               32.9799    39.6433    41.2847    62.5501    43.2657
  EC 1.2.1.16   evm.model.unitig_2.1270                               Succinate-semialdehyde dehydrogenase (NAD(P)^+^)             18.7586    31.3531    37.5994    46.1063    23.1694
  EC 1.2.1.16   evm.model.unitig_4.289                                aldehyde dehydrogenase family protein                         38.071    48.0361    28.8966    40.7511    50.4369
  EC 1.2.1.16   evm.model.unitig_5.338                                succinate-semialdehyde dehydrogenase (NADP)                  19.1193    9.30071    18.9276    47.9931    107.202
  EC 1.2.1.16   evm.model.unitig_5.445                                Succinate-semialdehyde dehydrogenase (NAD(P)^+^)             4.14887     7.1628     15.265     16.603    9.76361
  EC 1.2.1.16   evm.model.unitig_6.87                                 Glutarate-semialdehyde dehydrogenase                         18.0798    36.4844     40.734    41.9151    61.8611
  EC 4.1.1.15   evm.model.unitig_0.1336                               glutamate decarboxylase                                      19.2535    8.99677    7.21094    3.60937    5.17597
  EC 4.1.1.15   evm.model.unitig_1.1110                               glutamate decarboxylase 1                                    2129.58    2923.29    3713.03    3881.53    4501.63
  EC 4.1.1.15   evm.model.unitig_4.236[\*](#t2-fn1){ref-type="fn"}    glutamate decarboxylase 1                                     2.6946    2.51931    2.15859    5.39455    3.62821
  EC 1.4.1.4    evm.model.1.692                                       NADP-specific glutamate dehydrogenase                        81.1597    58.0026    33.3913    23.0803    29.9846
  EC 1.4.1.4    evm.model.unitig_0.768                                aminating glutamate dehydrogenases                           86.8852    147.377    105.387    250.044    189.577

^\*^Above the gene ID means the enzyme was located in mitochondrion.

###### Transporters regulated on transcriptional level during citrate fermentation.

  Gene ID                   Gene function                                            FPKM-6h   FPKM-12h   FPKM-24h   FPKM-36h   FPKM-48h
  ------------------------- ------------------------------------------------------- --------- ---------- ---------- ---------- ----------
  evm.model.unitig_3.636    ABC transporter C family member                          13.1977   35.3317    58.9041     46.401    37.9172
  evm.model.unitig_3.637    Canalicular multispecific organic anion transporter 1    28.5373   87.9929    149.208    97.0309    73.4379
  evm.model.unitig_3.640    Canalicular multispecific organic anion transporter 1    20.4793    107.35    223.035    296.068    305.751
  evm.model.unitig_0.1084   Canalicular multispecific organic anion transporter 2    8.0014    40.5062    79.4721    84.8434    60.4354
  evm.model.unitig_5.1021   Sodium/potassium-transporting ATPase subunit alpha-1     63.2289   130.481    286.188    272.621    353.328
  evm.model.1.100           succinate/fumarate transporter                           60.1747   7.32488    4.93716    3.10826    7.87887
  evm.model.1.1208          Uncharacterized transporter                              20.1262   657.514    638.877    605.893    604.348
  evm.model.1.31            Probable metabolite transport protein                    19.7919   47.7725    103.538    138.268    150.005
  evm.model.1.352           plasma membrane fusion protein prm1                      4.66831   21.8264    107.014    162.537    109.181
  evm.model.1.69            amino acid transporter                                   26.4711   6.00714    4.01169    3.26287    4.30079
  evm.model.1.857           Uncharacterized MFS-type transporter                     262.407   35.7379    29.1139     28.839    18.9121
  evm.model.unitig_0.1595   Uncharacterized transporter                              7.69787   24.2853    42.5223    80.5382    81.6519
  evm.model.unitig_0.437    quinate permease                                         2.52556   23.0903    55.1789    28.4854    22.4314
  evm.model.unitig_1.1394   MFS multidrug transporter                                1144.22   178.003    114.492    36.4788    28.1839
  evm.model.unitig_1.578    Mitochondrial 2-oxodicarboxylate carrier 2               826.306   390.695    405.997    283.533    284.765
  evm.model.unitig_2.1188   amino-acid permease inda1                                157.845   440.541    549.456    578.762    548.658
  evm.model.unitig_2.1237   MFS transporter                                          16.3143   61.9491    77.3993    77.3265    65.6228
  evm.model.unitig_2.1258   Glutathione transporter 1                                53.949    4.04985     2.2213    1.01079    0.489433
  evm.model.unitig_2.1390   vacuolar calcium ion transporter                         252.61    622.261    657.009    600.778    603.315
  evm.model.unitig_2.1392   vacuolar calcium ion transporter                         32.1809   68.8772    91.3865    94.9701    77.2152
  evm.model.unitig_2.45     MFS transporter                                          38.4455   12.7329    3.27757    1.25471    0.357967
  evm.model.unitig_2.532    calcium transporter                                      53.9308   119.391    153.595    189.557    130.659
  evm.model.unitig_2.827    urea active transporter 1                                15.9503    43.262    77.2426    53.5096     52.18
  evm.model.unitig_2.971    corA family metal ion transporter                        7.22867   189.826    347.136    300.912     301.19
  evm.model.unitig_3.1075   galactose-proton symport                                 687.339   254.727    116.009    82.0497    93.8167
  evm.model.unitig_3.1191   quinate permease                                            0      25.5055    36.3913     25.114    34.4627
  evm.model.unitig_3.62     ABC transporter                                          39.1748   78.3932    116.238    125.325    118.615
  evm.model.unitig_3.635    Oligopeptide transporter                                 14.6011   104.855    128.548     199.55    116.732
  evm.model.unitig_4.1038   Uncharacterized permease                                 63.5294   161.174    243.495    213.192     141.02
  evm.model.unitig_4.1122   Zinc-regulated transporter 1                             26.221    868.686    1163.35    831.676    662.476
  evm.model.unitig_4.29     MFS multidrug transporter                                28.1368   65.3458    79.5197    108.998    84.1431
  evm.model.unitig_4.558    sugar transporter                                        60.7082    28.922    24.2149    12.3733    23.8319
  evm.model.unitig_4.58     zinc-regulated transporter 1                             27.4409   86.7798    89.9594    104.495    106.612
  evm.model.unitig_4.660    MFS allantoate transporter                               9.26185   27.5775    126.026    91.9883    92.9983
  evm.model.unitig_4.694    Transport protein particle 20 kDa subunit                71.691    35.4592    31.7326    35.1786     31.681
  evm.model.unitig_4.966    copper transporter family protein                        89.4315    386.8     247.155    674.724    409.464
  evm.model.unitig_5.1028   Oligopeptide transporter                                 427.735   1076.43    1775.18    1632.03    1598.71
  evm.model.unitig_6.240    corA family metal ion transporter                        89.6403   201.674    232.638    230.226    243.676
  evm.model.unitig_6.447    monocarboxylate transporter                              50.1323   135.575    189.269    239.416    254.186
  evm.model.unitig_6.486    low affinity iron transporter                            3.69287   73.9308    190.217    325.134    557.337
  evm.model.unitig_6.549    Purine-cytosine permease fcyB                            59.0138   194.498    328.304    284.184    176.873
  evm.model.unitig_6.821    MFS toxin efflux pump                                    49.4076   103.654    164.539    173.255    159.919
  evm.model.unitig_6.853    Choline transport protein                                3.65766    51.889    48.6358     93.561    47.9792
  evm.model.unitig_6.875    MFS transporter                                          2.1797    23.2597     24.884    45.0643    33.2642
  evm.model.unitig_3.110    Hexose transporter                                       5.8594    29.5108     54.735     74.547    275.829
  evm.model.unitig_3.919    OPT oligopeptide transporter family                      3.40145   42.7754    192.636    367.982    323.622
